Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Matsuo M, Iwanaga M, Kondo H, Soda M, Jo T, Horio K, Takasaki Y, Kawaguchi Y, Tsushima H, Imaizumi Y, Imanishi D, Taguchi J, Sawayama Y, Hata T, Miyazaki Y.

Cancer Sci. 2016 Oct;107(10):1484-1491. doi: 10.1111/cas.13025.

2.

Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome.

Ali SF, Sonu RJ, Dwyre DM, Jonas BA, Rashidi HH.

Case Rep Hematol. 2015;2015:318545. doi: 10.1155/2015/318545.

3.

TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.

Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Peng J, Tang G, Goswami M, Young KH, Singh R, Medeiros LJ, Kantarjian HM, Luthra R, Wang SA.

J Hematol Oncol. 2015 May 8;8:45. doi: 10.1186/s13045-015-0139-z.

4.

Secondary acute promyelocytic leukemia following chemotherapy for gastric cancer: a case report.

Zhang YC, Zhou YQ, Yan B, Shi J, Xiu LJ, Sun YW, Liu X, Qin ZF, Wei PK, Li YJ.

World J Gastroenterol. 2015 Apr 14;21(14):4402-7. doi: 10.3748/wjg.v21.i14.4402.

5.

A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Zhang L, Wang SA.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3512-23. Review.

6.

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Quintás-Cardama A, Daver N, Kim H, Dinardo C, Jabbour E, Kadia T, Borthakur G, Pierce S, Shan J, Cardenas-Turanzas M, Cortes J, Ravandi F, Wierda W, Estrov Z, Faderl S, Wei Y, Kantarjian H, Garcia-Manero G.

Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):401-10. doi: 10.1016/j.clml.2014.03.001.

7.

Severe Aplastic Anemia Manifesting After Complete Remission of Acute Promyelocytic Leukemia: Is it a Fortuitous Association?

Handigund RS, Malur PR, Dhumale AJ, Bali A, Roy M, Inumella S.

Indian J Hematol Blood Transfus. 2014 Mar;30(1):64-7. doi: 10.1007/s12288-012-0201-8.

8.

Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Natelson EA, Pyatt D.

Adv Hematol. 2013;2013:309637. doi: 10.1155/2013/309637. Review.

9.

Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia.

Park SH, Chi HS, Cho YU, Jang S, Park CJ.

Blood Res. 2013 Sep;48(3):185-92. doi: 10.5045/br.2013.48.3.185.

10.

The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.

Fu B, Ok CY, Goswami M, Xei W, Jaso JM, Muzzafar T, Bueso-Ramos C, Verstovsek S, Garcia-Manero G, Medeiros LJ, Wang SA.

Ann Hematol. 2013 Oct;92(10):1335-43. doi: 10.1007/s00277-013-1776-3.

11.

Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.

Huh HJ, Lee SH, Yoo KH, Sung KW, Koo HH, Kim K, Jang JH, Jung C, Kim SH, Kim HJ.

Ann Lab Med. 2013 Mar;33(2):97-104. doi: 10.3343/alm.2013.33.2.97.

12.

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.

J Clin Oncol. 2012 Jul 1;30(19):2340-7. doi: 10.1200/JCO.2011.38.7340.

13.

Therapy-related myeloid malignancies in myeloma.

Papanikolaou X, Barlogie B, Usmani SZ.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011047. doi: 10.4084/MJHID.2011.047.

14.

Acute myeloid leukemia with expanded erythropoiesis.

Porwit A, Vardiman JW.

Haematologica. 2011 Sep;96(9):1241-3. doi: 10.3324/haematol.2011.050526. No abstract available.

15.

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Sill H, Olipitz W, Zebisch A, Schulz E, Wölfler A.

Br J Pharmacol. 2011 Feb;162(4):792-805. doi: 10.1111/j.1476-5381.2010.01100.x. Review.

16.

Temozolomide-induced myelodysplasia.

Natelson EA, Pyatt D.

Adv Hematol. 2010;2010:760402. doi: 10.1155/2010/760402.

17.

Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.

Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA.

Blood. 2010 Mar 11;115(10):1985-92. doi: 10.1182/blood-2009-09-243964.

18.

Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.

Tokuhira M, Hanzawa K, Watanabe R, Sekiguchi Y, Nemoto T, Toyozumi Y, Tamaru J, Itoyama S, Suzuki K, Kameda H, Mori S, Kizaki M.

J Hematol Oncol. 2009 Jun 30;2:27. doi: 10.1186/1756-8722-2-27.

19.

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

Kröger N, Brand R, van Biezen A, Zander A, Dierlamm J, Niederwieser D, Devergie A, Ruutu T, Cornish J, Ljungman P, Gratwohl A, Cordonnier C, Beelen D, Deconinck E, Symeonidis A, de Witte T; Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT)..

Haematologica. 2009 Apr;94(4):542-9. doi: 10.3324/haematol.2008.000927.

Supplemental Content

Support Center